An inactivated enterovirus 71 vaccine in healthy children.
about
Enterovirus and parechovirus infection in children: a brief overviewMicroRNA and Pathogenesis of Enterovirus InfectionRecent Progress towards Novel EV71 Anti-Therapeutics and VaccinesIs a multivalent hand, foot, and mouth disease vaccine feasible?Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic MouseThe Current Status of the Disease Caused by Enterovirus 71 Infections: Epidemiology, Pathogenesis, Molecular Epidemiology, and Vaccine DevelopmentEnterovirus 71 infection and neurological complicationsThe Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan SulfateEfficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in MiceEnterovirus 71 infection and vaccines.Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).EV71 vaccines: a milestone in the history of global vaccine developmentCrystal structure of 2C helicase from enterovirus 71Dynamic Interaction of Enterovirus 71 and Dendritic Cells in Infected Neonatal Rhesus MacaquesDifferent microRNA profiles reveal the diverse outcomes induced by EV71 and CA16 infection in human umbilical vein endothelial cells using high-throughput sequencing.Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.Persistent circulation of Coxsackievirus A6 of genotype D3 in mainland of China between 2008 and 2015.Regulatory science accelerates the development of biotechnology drugs and vaccines by NIFDCEV71 vaccine, an invaluable gift for children.The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication.Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008-2013The Fecal Virome of Children with Hand, Foot, and Mouth Disease that Tested PCR Negative for Pathogenic Enteroviruses.Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations.Epidemiological Characteristics and Spatial-Temporal Clusters of Hand, Foot, and Mouth Disease in Zhejiang Province, China, 2008-2012Phylodynamics of Enterovirus A71-Associated Hand, Foot, and Mouth Disease in Viet Nam.A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71.Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness AnalysisStructures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients.Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.Disease burden of enterovirus 71 in rural central China: A community-based survey.The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.Acute Flaccid Paralysis: The New, The Old, and The Preventable.Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis.Identification of a nucleotide in 5' untranslated region contributing to virus replication and virulence of Coxsackievirus A16Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease.Hand, Foot, and Mouth Disease in China: Critical Community Size and Spatial Vaccination Strategies.
P2860
Q26751373-EBEB2BB9-F31A-41E2-9AC7-1420E8F39700Q26769980-7E19FCA1-51FE-4CD6-809D-89BCA1923BDCQ26775734-686DD8E0-699C-4043-A256-FE35C6E950E2Q27010349-A03CC620-F8CF-4139-9B41-240519109F45Q27321616-C42E6DDA-60C0-4877-87E9-ADFAEA39B7C5Q28066400-FEE3F6AC-1AAE-4DAA-90BB-C563DFA3A5A5Q28072189-C34C87C7-1F23-47C2-98E2-116DAFFF1CDEQ28550039-88299EF1-1689-4867-AEC6-65FF96644350Q28606867-5F0DCBFF-D4DA-404B-A963-6FEFA4F42EF6Q30238518-8919B281-5B72-433F-880E-72DAF484B483Q30249022-8EDB5611-292B-41C5-9969-16A44943F5A2Q30383172-8EF88DA4-4764-444B-916B-2D651E55E242Q33561240-78E36E96-E995-4889-9810-7EF118806373Q33615630-2F82D7F1-025E-45BB-984E-070D0F27A4EEQ33653696-8A73B49B-1964-4F20-A544-8D0A56A86784Q33713090-B8029B90-94E4-4683-9D67-99A3EF87146EQ33809953-FC7BB6C9-257C-4159-A5D6-ACFF5E5C8639Q33887710-F5ADC19B-BCB7-4B1D-BC4E-2C69A2521CC2Q33905640-7CCA1515-7114-4E23-B6AE-214416D23DCCQ34289974-2B676B09-59D5-44A3-A3FF-F6AD966A72B2Q34540559-4A54EE1F-24E8-40FF-BB6B-312F7FBD6E0DQ34596364-189BCB51-F85C-45E5-894B-69D1DFA9A1E1Q35160633-63B9F290-9223-4B42-A297-E6A9E2187EC1Q35750329-00B01AB5-D5E2-46CA-BC98-C2EFB9D68915Q35779269-7127E918-15CB-4356-A574-93CFF5F73FA7Q35793525-A241B30B-0DD1-45EB-A50F-F1379A5E3D54Q35913916-173C1414-97C0-41CB-A74B-C9B4982531CBQ35917729-DB27B852-B634-4B60-A39C-7ECE34074C6CQ35925175-BAF139C7-3CF0-4DCD-B28C-B92D7439E1F1Q35957814-E4BFCBA9-F9AE-47EC-8B43-F0D4CDABA7B3Q36086365-713B9165-508F-4950-9BD9-B91520BE9755Q36180348-BF1089EC-1FD9-4B3E-97F2-035B7511C447Q36256455-D1DCCF0D-90CD-4D26-A57F-EF60CBDD0B79Q36256473-461ED671-700C-47E2-B65F-BF882FA9FE92Q36389012-9A305118-96F7-4C8F-9986-6A669DC16EBFQ36472521-BB0F4489-6326-4229-9915-C3809872D136Q36479953-B28A915C-D6B1-4E8D-9964-7B6C9970B7FFQ36565546-401F8CEE-10F1-4461-B6E0-5047BE1BEB10Q36713602-B100F93E-F00B-47A4-8785-DA929F8461E0Q36850531-3A593A01-86D1-4FEE-8533-E01E8424DF24
P2860
An inactivated enterovirus 71 vaccine in healthy children.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
An inactivated enterovirus 71 vaccine in healthy children.
@en
type
label
An inactivated enterovirus 71 vaccine in healthy children.
@en
prefLabel
An inactivated enterovirus 71 vaccine in healthy children.
@en
P2093
P356
P1476
An inactivated enterovirus 71 vaccine in healthy children.
@en
P2093
Chenghong Dong
Erxia Yang
Haijing Shi
Hongling Zhao
Jiansheng Liu
Jielai Xia
Jingjing Wang
Junzhi Wang
P304
P356
10.1056/NEJMOA1303224
P407
P577
2014-02-01T00:00:00Z